Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.43 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7904469 | 0.96 | ESR1 (0.45) | AKR1C1CYP2D6ALDH1A1MAPTMTNR1A | |
| SCHEMBL4199808 | 0.88 | ESR1 (0.58) | CYP2D6MAPTESR1KMT2AMEN1 | |
| SCHEMBL305384 | 0.87 | CYP19A1 (0.50) | CYP2D6ALDH1A1MAPTMAPK1KMT2A | |
| Hydrochloric Acid SCHEMBL9803951 | 0.85 | CYP19A1 (0.49) | CYP2D6ALDH1A1MAPTMAPK1KMT2A | |
| SCHEMBL7944757 | 0.85 | ALDH1A1 (0.48) | AKR1C1CYP2D6ALDH1A1MAPTTSHR | |
| SCHEMBL12411237 | 0.82 | KMT2A (0.47) | AKR1C1CYP2D6ALDH1A1MAPTMTNR1A | |
| SCHEMBL2992588 | 0.81 | LCK (0.41) | AKR1C1ALDH1A1MAPTMAPK1RAB9A | |
| SCHEMBL2992590 | 0.81 | LCK (0.41) | AKR1C1ALDH1A1MAPTMAPK1RAB9A | |
| SCHEMBL2992596 | 0.80 | MAPT (0.39) | ALDH1A1MAPTRAB9ALMNAGAA | |
| SCHEMBL27808829 | 0.80 | CYP1B1 (0.47) | ALDH1A1MAPTMAPK1AKR1C3KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 388 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3262055-B1 | WATER SOLUBLE FLUORESCENT OR COLORED DYES COMPRISING CONJUGATING GROUPS | SONY GROUP CORP (JP) | 2026-04-22 | — | — | EP | claimed |
| EP-4137818-B1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | SONY GROUP CORP (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-3440136-B1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES WITH SPACING LINKER GROUPS | SONY GROUP CORP (JP) | 2025-07-23 | — | — | EP | claimed |
| US-12359071-B2 | Polymeric tandem dyes with linker groups | Sony Group Corporation (JP) | 2025-07-15 | — | — | US | claimed |
| WO-2025047293-A1 | COMPOUND, DETECTION SYSTEM, AND MEASUREMENT DEVICE | ソニーグループ株式会社 | 2025-03-06 | — | — | WO | claimed |
| US-20250009898-A1 | PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT | SONY GROUP CORP (JP) | 2025-01-09 | — | — | US | claimed |
| US-20250009786-A1 | AUTOMATED SYNTHESIS OF POLYMERIC DUAL DRUGS | Sony Group Corporation (JP) | 2025-01-09 | — | — | US | claimed |
| US-20240294767-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | SONY GROUP CORP (JP) | 2024-09-05 | — | — | US | claimed |
| EP-4408473-A1 | AUTOMATED SYNTHESIS OF POLYMERIC DUAL DRUGS | Sony Group Corporation (JP) | 2024-08-07 | — | — | EP | claimed |
| US-20240210408-A1 | USE OF DIVALENT METALS FOR ENHANCEMENT OF FLUORESCENT SIGNALS | SONY GROUP CORP (JP) | 2024-06-27 | — | — | US | claimed |
| US-7423133-B2 | Fluorescent glycosides and methods for their use | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2008-09-09 | — | — | US | claimed |
| US-20040215012-A1 | FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2004-10-28 | — | — | US | claimed |
| WO-2004019002-A2 | FLUORESCENT GLYCOSIDES AND METHODS FOR THEIR USE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2004-03-04 | — | — | WO | claimed |
| US-6670193-B2 | Coupling with organometallic compound; emission light | RESEARCH CORPORATION TECHNOLOGIES, INC. | 2003-12-30 | — | — | US | claimed |
| US-6479650-B1 | Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same | RESEARCH CORPORATION TECHNOLOGIES, INC. | 2002-11-12 | — | — | US | claimed |
| US-20020160411-A1 | Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 2002-10-31 | — | — | US | claimed |
| WO-2001044220-A2 | FLUORESCENT NUCLEOSIDE ANALOGS AND COMBINATORIAL FLUOROPHORE ARRAYS COMPRISING SAME | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| EP-0026088-B1 | PHOTORESIST COMPOSITIONS | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1983-11-23 | — | — | EP | claimed |
| US-4349619-A | CONTAINING ANTIHALATION AGENTS | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1982-09-14 | — | — | US | claimed |
| EP-0026088-A2 | Photoresist compositions | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1981-04-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020160411-A1 | Fluorescent nucleoside analogs and combinatorial fluorophore arrays comprising same | DERA, FBL, DUT | AKR1C1 1780/4885CYP2D6 1525/4885ALDH1A1 1698/4885 |
| US-12359071-B2 | Polymeric tandem dyes with linker groups | CHRM1, IK, TMT1A | AKR1C1 1436/4885CYP2D6 3656/4885ALDH1A1 1531/4885 |
| US-20250009898-A1 | PYRROLOBENZODIAZEPINE CONJUGATES FOR CANCER TREATMENT | CHRM1, TPD52L2, H1-3 | AKR1C1 3605/4885CYP2D6 496/4885ALDH1A1 1901/4885 |
| US-20250009786-A1 | AUTOMATED SYNTHESIS OF POLYMERIC DUAL DRUGS | CHRM1, CHRM2, H1-0 | AKR1C1 2990/4885CYP2D6 196/4885ALDH1A1 1723/4885 |
| US-20240294767-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | CHRM1, IK, TMT1A | AKR1C1 1436/4885CYP2D6 3656/4885ALDH1A1 1531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.